| Patent | Date |
|---|
Uridine phosphorylase (UPase) inhibitors for treatment of liver conditions
Grant 11,446,303 - Garland , et al. September 20, 2 | 2022-09-20 |
Modulators of RAS GTPase
App 20220227740 - Ungashe; Solomon B. ; et al. | 2022-07-21 |
Pyrazolopyrimidine modulators of RAS GTPase
Grant 11,390,626 - Garland , et al. July 19, 2 | 2022-07-19 |
Small Molecule Modulators of RAS GTPase
App 20220112178 - Ungashe; Solomon B. ; et al. | 2022-04-14 |
Heteroaryl Modulators of RAS GTPase
App 20220112205 - Ungashe; Solomon B. ; et al. | 2022-04-14 |
Uridine Phosphorylase Inhibitors to Treat or Prevent Pulmonary Disease
App 20220008422 - Garland; William A. ; et al. | 2022-01-13 |
Modulators of RAS GTPase
App 20210261532 - Lennek; Annie L. ; et al. | 2021-08-26 |
Methods and Compositions for Treating Mucositis
App 20210236530 - Garland; William A. ; et al. | 2021-08-05 |
Methods and Compositions for Reducing Radiation Induced Toxicity
App 20210228583 - Garland; William A. ; et al. | 2021-07-29 |
Methods and Compositions for Maximizing the Prevention and/or Reduction of Various Maladies and Drug Side-Effects Using Uridine
App 20210228584 - Garland; William A. ; et al. | 2021-07-29 |
Uridine Phosphorylase (UPase) Inhibitors for Treatment of Liver Conditions
App 20200397790 - Garland; William A. ; et al. | 2020-12-24 |
Non-Mammalian RAS Transgenic Animal Model
App 20200390074 - Karg; Travis ; et al. | 2020-12-17 |
Methotrexate adjuvants to reduce toxicity and methods for using the same
Grant RE48,253 - Garland , et al. October 13, 2 | 2020-10-13 |
Pyrazolopyrimidine Modulators of RAS GTPase
App 20200239479 - Garland; William A. ; et al. | 2020-07-30 |
Non-mammalian RAS transgenic animal model
Grant 10,660,318 - Karg , et al. | 2020-05-26 |
Doxorubicin adjuvants to reduce toxicity and methods for using the same
Grant 9,468,613 - Garland , et al. October 18, 2 | 2016-10-18 |
Non-Mammalian RAS Transgenic Animal Model
App 20160249593 - Karg; Travis ; et al. | 2016-09-01 |
Methotrexate adjuvants to reduce toxicity and methods for using the same
Grant 9,382,287 - Garland , et al. July 5, 2 | 2016-07-05 |
Doxorubicin Adjuvants to Reduce Toxicity and Methods for Using the Same
App 20150258046 - Garland; William A. ; et al. | 2015-09-17 |
Doxorubicin adjuvants to reduce toxicity and methods for using the same
Grant 9,061,038 - Garland , et al. June 23, 2 | 2015-06-23 |
Methotrexate Adjuvants to Reduce Toxicity and Methods for Using the Same
App 20150072945 - Garland; William A. ; et al. | 2015-03-12 |
Methotrexate adjuvants to reduce toxicity and methods for using the same
Grant 8,853,227 - Garland , et al. October 7, 2 | 2014-10-07 |
Doxorubicin adjuvants to reduce toxicity and methods for using the same
Grant 8,227,517 - Garland , et al. July 24, 2 | 2012-07-24 |
Methotrexate adjuvants to reduce toxicity and methods for using the same
Grant 7,998,967 - Garland , et al. August 16, 2 | 2011-08-16 |
Non-mammalian Transgenic Animal Model For Cellular Proliferative Diseases
App 20080189798 - Fogarty; Patrick | 2008-08-07 |
In vivo high throughput toxicology screening method
Grant 6,855,504 - Fogarty February 15, 2 | 2005-02-15 |
Methods and compositions for use in homologous recombination
App 20040043486 - Fogarty, Patrick | 2004-03-04 |
Methods and compositions for use in homologous recombination
App 20030203487 - Fogarty, Patrick | 2003-10-30 |
P element derived vector and methods for its use
Grant 6,475,798 - Fogarty , et al. November 5, 2 | 2002-11-05 |
P element derived vector and methods for its use
Grant 6,291,243 - Fogarty , et al. September 18, 2 | 2001-09-18 |
| 